Analyst Rating In Review: Endo Pharmaceuticals Bid Up 8.6% Since Downgraded 7 Days Ago (ENDP)

Published on Thu, 02/07/2013 - 10:09
By Robert Cotter in Analyst reflections, ENDP, analyst reflections, endo pharmaceuticals, nasdaq:endp

A week ago, Oppenheimer downgraded Endo Pharmaceuticals from Outperform to Perform. The stock closed at $30.66, which is 8.6% higher than the price one week ago ($28.23).

In the past 52 weeks, shares of Endo Pharmaceuticals have traded between a low of $25.00 and a high of $44.53 and are now at $30.40, which is 22% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has advanced 0.7%.

There is potential upside of 9.6% for shares of Endo Pharmaceuticals based on a current price of $30.40 and an average consensus analyst price target of $33.31. The stock should find initial support at its 200-day moving average (MA) of $30.27 and further support at its 50-day MA of $27.56.

Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo's products include Percocet, Percodan, and Lidoderm.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Earnings Flashback: Since Reporting Quar...

18 days ago, on July 8th, 2014, Bob Evans Farms (NASDAQ:BOBE) reported its earnings. A ...

Earnings Flashback: Since Reporting Quar...

11 days ago, on July 15th, 2014, CSX (NYSE:CSX) reported its earnings. Analysts, on av ...

Dover Earnings Review: 9 Days after Anno...

When Dover (NYSE:DOV) reported earnings 9 days ago on July 17th, 2014, analysts, on ave ...

Earnings Look Back: Autoliv Is Down 0.3%...

A week ago on July 18th, 2014 Autoliv (NYSE:ALV) reported earnings and analysts, on ave ...

Earnings Flashback: Since Reporting Quar...

A week ago on July 18th, 2014 Kansas City Southern (NYSE:KSU) reported earnings and ana ...

Cytec Industries Earnings Hindsight: Up ...

When Cytec Industries (NYSE:CYT) reported earnings a week ago on July 17th, 2014, analy ...

Novartis Earnings Hindsight: Down 0.1% i...

When Novartis (NYSE:NVS) reported earnings 9 days ago on July 17th, 2014, analysts, on ...

Post Earnings Update: AAR Has Climbed 4....

11 days ago, on July 15th, 2014, AAR (NYSE:AIR) reported its earnings. Analysts, on av ...